 Jose Diaz-Miron
Concepts (211)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Extracorporeal Membrane Oxygenation | 2 | 2025 | 333 | 1.400 |
Why?
| | Intestine, Small | 8 | 2017 | 155 | 1.140 |
Why?
| | Surgeons | 5 | 2023 | 316 | 1.070 |
Why?
| | Central Venous Catheters | 1 | 2023 | 51 | 0.810 |
Why?
| | Renal Insufficiency | 1 | 2025 | 163 | 0.800 |
Why?
| | Intestinal Atresia | 1 | 2023 | 15 | 0.790 |
Why?
| | Needs Assessment | 1 | 2025 | 381 | 0.780 |
Why?
| | Catheter-Related Infections | 1 | 2023 | 89 | 0.780 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2025 | 270 | 0.750 |
Why?
| | Clinical Decision-Making | 1 | 2025 | 335 | 0.750 |
Why?
| | Catheterization, Central Venous | 1 | 2023 | 113 | 0.740 |
Why?
| | Myofibromatosis | 1 | 2021 | 9 | 0.730 |
Why?
| | Heart Arrest | 1 | 2025 | 365 | 0.700 |
Why?
| | Gastrostomy | 4 | 2025 | 118 | 0.670 |
Why?
| | Decision Making | 2 | 2025 | 946 | 0.660 |
Why?
| | Adaptation, Physiological | 6 | 2017 | 554 | 0.650 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2023 | 397 | 0.570 |
Why?
| | Wounds and Injuries | 2 | 2024 | 781 | 0.570 |
Why?
| | Infant, Newborn | 8 | 2025 | 6152 | 0.550 |
Why?
| | Neovascularization, Physiologic | 3 | 2015 | 182 | 0.540 |
Why?
| | Short Bowel Syndrome | 5 | 2017 | 27 | 0.490 |
Why?
| | Lung Diseases | 1 | 2022 | 783 | 0.460 |
Why?
| | Coronary Aneurysm | 1 | 2014 | 14 | 0.440 |
Why?
| | Appendectomy | 2 | 2025 | 89 | 0.430 |
Why?
| | Hepatoblastoma | 2 | 2024 | 45 | 0.410 |
Why?
| | Thoracic Injuries | 1 | 2014 | 63 | 0.410 |
Why?
| | Telemedicine | 2 | 2025 | 867 | 0.410 |
Why?
| | Baseball | 1 | 2014 | 60 | 0.400 |
Why?
| | Specialties, Surgical | 2 | 2025 | 76 | 0.400 |
Why?
| | Hemostasis | 1 | 2013 | 87 | 0.400 |
Why?
| | Appendicitis | 2 | 2025 | 140 | 0.390 |
Why?
| | Hematopoiesis | 1 | 2013 | 193 | 0.380 |
Why?
| | Child | 17 | 2025 | 21906 | 0.370 |
Why?
| | Retrospective Studies | 14 | 2025 | 15922 | 0.350 |
Why?
| | Wounds, Nonpenetrating | 1 | 2014 | 289 | 0.340 |
Why?
| | Lung | 1 | 2022 | 4094 | 0.290 |
Why?
| | Intestinal Mucosa | 5 | 2017 | 621 | 0.280 |
Why?
| | Infant | 11 | 2025 | 9576 | 0.280 |
Why?
| | Humans | 31 | 2025 | 139062 | 0.270 |
Why?
| | Liver Neoplasms | 2 | 2024 | 761 | 0.270 |
Why?
| | Length of Stay | 4 | 2025 | 1235 | 0.260 |
Why?
| | Clinical Protocols | 2 | 2025 | 274 | 0.260 |
Why?
| | Receptor, IGF Type 1 | 2 | 2017 | 64 | 0.240 |
Why?
| | Insulin-Like Growth Factor II | 2 | 2017 | 22 | 0.240 |
Why?
| | Retinoblastoma Protein | 2 | 2017 | 57 | 0.240 |
Why?
| | Gastroschisis | 1 | 2025 | 29 | 0.230 |
Why?
| | Sutures | 1 | 2025 | 59 | 0.230 |
Why?
| | Chemokine CXCL5 | 2 | 2015 | 12 | 0.220 |
Why?
| | Digestive System Abnormalities | 1 | 2024 | 20 | 0.220 |
Why?
| | Anastomotic Leak | 1 | 2024 | 42 | 0.220 |
Why?
| | Trisomy 18 Syndrome | 1 | 2024 | 5 | 0.220 |
Why?
| | Suture Techniques | 1 | 2025 | 122 | 0.220 |
Why?
| | Male | 18 | 2025 | 68324 | 0.220 |
Why?
| | Intestinal Volvulus | 1 | 2024 | 22 | 0.220 |
Why?
| | Esophageal Atresia | 1 | 2024 | 26 | 0.220 |
Why?
| | Hospitals, Pediatric | 2 | 2025 | 518 | 0.220 |
Why?
| | Competency-Based Education | 1 | 2025 | 70 | 0.220 |
Why?
| | Tracheoesophageal Fistula | 1 | 2024 | 33 | 0.220 |
Why?
| | Critical Pathways | 1 | 2025 | 97 | 0.210 |
Why?
| | Gastric Fistula | 1 | 2024 | 9 | 0.210 |
Why?
| | Female | 17 | 2025 | 74074 | 0.200 |
Why?
| | Trauma Centers | 2 | 2024 | 420 | 0.200 |
Why?
| | Postoperative Care | 1 | 2025 | 274 | 0.200 |
Why?
| | Pandemics | 2 | 2022 | 1650 | 0.200 |
Why?
| | Pneumatosis Cystoides Intestinalis | 1 | 2023 | 21 | 0.200 |
Why?
| | Enoxaparin | 1 | 2023 | 64 | 0.190 |
Why?
| | Perioperative Care | 1 | 2025 | 214 | 0.190 |
Why?
| | Preoperative Care | 1 | 2024 | 368 | 0.190 |
Why?
| | Interviews as Topic | 1 | 2025 | 806 | 0.180 |
Why?
| | False Positive Reactions | 1 | 2022 | 125 | 0.180 |
Why?
| | Scalp | 1 | 2021 | 35 | 0.180 |
Why?
| | Surgical Wound Infection | 1 | 2025 | 311 | 0.180 |
Why?
| | Fellowships and Scholarships | 1 | 2025 | 311 | 0.170 |
Why?
| | Photography | 1 | 2021 | 107 | 0.170 |
Why?
| | Guideline Adherence | 1 | 2025 | 557 | 0.170 |
Why?
| | Intestinal Obstruction | 1 | 2021 | 51 | 0.170 |
Why?
| | Operating Rooms | 1 | 2022 | 142 | 0.170 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2024 | 359 | 0.160 |
Why?
| | Education, Medical, Graduate | 1 | 2025 | 495 | 0.160 |
Why?
| | Healthcare Disparities | 2 | 2024 | 661 | 0.160 |
Why?
| | Transgender Persons | 1 | 2023 | 187 | 0.160 |
Why?
| | Pregnancy Outcome | 1 | 2023 | 429 | 0.160 |
Why?
| | Patient Education as Topic | 1 | 2025 | 763 | 0.160 |
Why?
| | Thrombosis | 1 | 2023 | 383 | 0.150 |
Why?
| | Prospective Studies | 2 | 2022 | 7660 | 0.150 |
Why?
| | Neuroblastoma | 2 | 2011 | 161 | 0.150 |
Why?
| | Adolescent | 7 | 2025 | 21561 | 0.150 |
Why?
| | Qualitative Research | 1 | 2025 | 1445 | 0.140 |
Why?
| | Mice, Knockout | 5 | 2017 | 3038 | 0.140 |
Why?
| | Cardiac Surgical Procedures | 1 | 2024 | 576 | 0.140 |
Why?
| | Feasibility Studies | 1 | 2022 | 977 | 0.140 |
Why?
| | Postoperative Complications | 3 | 2025 | 2738 | 0.140 |
Why?
| | Patient Satisfaction | 1 | 2021 | 683 | 0.130 |
Why?
| | Infant, Premature | 1 | 2021 | 580 | 0.130 |
Why?
| | Clinical Competence | 1 | 2025 | 1140 | 0.130 |
Why?
| | Curriculum | 1 | 2023 | 1010 | 0.130 |
Why?
| | Sensitivity and Specificity | 1 | 2022 | 1958 | 0.130 |
Why?
| | Pediatrics | 1 | 2025 | 1076 | 0.130 |
Why?
| | Heart Defects, Congenital | 1 | 2024 | 850 | 0.130 |
Why?
| | Head and Neck Neoplasms | 1 | 2021 | 554 | 0.130 |
Why?
| | Treatment Outcome | 3 | 2025 | 10961 | 0.120 |
Why?
| | Incidence | 1 | 2023 | 2836 | 0.120 |
Why?
| | Parents | 1 | 2025 | 1421 | 0.120 |
Why?
| | Burnout, Professional | 1 | 2022 | 450 | 0.120 |
Why?
| | Child, Preschool | 6 | 2025 | 11142 | 0.120 |
Why?
| | Mice, Inbred C57BL | 6 | 2015 | 5813 | 0.120 |
Why?
| | Intestinal Absorption | 1 | 2015 | 93 | 0.110 |
Why?
| | Enterocytes | 1 | 2014 | 16 | 0.110 |
Why?
| | Anti-Bacterial Agents | 1 | 2025 | 1811 | 0.110 |
Why?
| | Extracorporeal Circulation | 1 | 2013 | 13 | 0.110 |
Why?
| | Vitamin K Deficiency Bleeding | 1 | 2013 | 4 | 0.110 |
Why?
| | Digestive System Surgical Procedures | 1 | 2014 | 105 | 0.100 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2013 | 35 | 0.100 |
Why?
| | Dietary Proteins | 1 | 2014 | 135 | 0.100 |
Why?
| | Caregivers | 1 | 2021 | 905 | 0.100 |
Why?
| | Body Composition | 2 | 2014 | 696 | 0.100 |
Why?
| | Intracranial Hemorrhages | 1 | 2013 | 89 | 0.100 |
Why?
| | Diet, High-Fat | 1 | 2014 | 248 | 0.100 |
Why?
| | ErbB Receptors | 1 | 2015 | 613 | 0.090 |
Why?
| | Tomography, X-Ray Computed | 1 | 2022 | 2706 | 0.090 |
Why?
| | Weight Gain | 1 | 2014 | 538 | 0.090 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 1 | 2011 | 66 | 0.080 |
Why?
| | Real-Time Polymerase Chain Reaction | 3 | 2017 | 349 | 0.080 |
Why?
| | Pregnancy | 1 | 2023 | 6874 | 0.080 |
Why?
| | Imidazoles | 1 | 2011 | 240 | 0.080 |
Why?
| | Angiogenesis Inhibitors | 1 | 2011 | 230 | 0.080 |
Why?
| | Neovascularization, Pathologic | 1 | 2011 | 296 | 0.080 |
Why?
| | Patient Readmission | 2 | 2025 | 706 | 0.070 |
Why?
| | Piperazines | 1 | 2011 | 349 | 0.070 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2011 | 551 | 0.070 |
Why?
| | Animals | 9 | 2017 | 37351 | 0.070 |
Why?
| | Bacteria | 1 | 2014 | 868 | 0.070 |
Why?
| | RNA | 1 | 2014 | 930 | 0.070 |
Why?
| | Enteral Nutrition | 2 | 2023 | 201 | 0.070 |
Why?
| | Microbiota | 1 | 2014 | 760 | 0.060 |
Why?
| | Neoplasm Proteins | 1 | 2009 | 433 | 0.060 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2011 | 816 | 0.060 |
Why?
| | Selenium | 1 | 2025 | 47 | 0.060 |
Why?
| | Cellulitis | 1 | 2025 | 55 | 0.060 |
Why?
| | Mice | 7 | 2017 | 17867 | 0.060 |
Why?
| | Postoperative Period | 2 | 2017 | 358 | 0.060 |
Why?
| | Gene Expression Regulation | 1 | 2014 | 2602 | 0.050 |
Why?
| | Thoracoscopy | 1 | 2024 | 55 | 0.050 |
Why?
| | Antibiotic Prophylaxis | 1 | 2025 | 122 | 0.050 |
Why?
| | Anastomosis, Surgical | 1 | 2024 | 159 | 0.050 |
Why?
| | Random Allocation | 2 | 2014 | 364 | 0.050 |
Why?
| | Disease Models, Animal | 4 | 2014 | 4339 | 0.050 |
Why?
| | Shock | 1 | 2024 | 99 | 0.050 |
Why?
| | Intubation, Gastrointestinal | 1 | 2024 | 77 | 0.050 |
Why?
| | Membrane Proteins | 1 | 2009 | 1153 | 0.050 |
Why?
| | Injury Severity Score | 1 | 2024 | 521 | 0.050 |
Why?
| | Gender Identity | 1 | 2023 | 125 | 0.050 |
Why?
| | Disposable Equipment | 1 | 2022 | 21 | 0.050 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2025 | 260 | 0.050 |
Why?
| | Adenoidectomy | 1 | 2022 | 72 | 0.050 |
Why?
| | Heparin | 1 | 2023 | 262 | 0.050 |
Why?
| | United States | 3 | 2024 | 15065 | 0.040 |
Why?
| | Contrast Media | 1 | 2024 | 473 | 0.040 |
Why?
| | Adhesives | 1 | 2021 | 13 | 0.040 |
Why?
| | Hospital Costs | 1 | 2022 | 120 | 0.040 |
Why?
| | Blood Coagulation | 1 | 2023 | 265 | 0.040 |
Why?
| | Tissue Adhesions | 1 | 2021 | 32 | 0.040 |
Why?
| | Cell Proliferation | 3 | 2015 | 2486 | 0.040 |
Why?
| | Laparoscopy | 1 | 2025 | 453 | 0.040 |
Why?
| | Intestines | 1 | 2023 | 358 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2014 | 1734 | 0.040 |
Why?
| | Medicaid | 1 | 2024 | 448 | 0.040 |
Why?
| | Pilot Projects | 1 | 2025 | 1763 | 0.040 |
Why?
| | Socioeconomic Factors | 1 | 2024 | 1310 | 0.040 |
Why?
| | Surveys and Questionnaires | 2 | 2022 | 5892 | 0.040 |
Why?
| | Databases, Factual | 1 | 2024 | 1404 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2014 | 2822 | 0.030 |
Why?
| | Apoptosis | 2 | 2015 | 2559 | 0.030 |
Why?
| | Glucose Transporter Type 2 | 1 | 2014 | 15 | 0.030 |
Why?
| | Sodium-Glucose Transporter 1 | 1 | 2014 | 11 | 0.030 |
Why?
| | Fish Oils | 1 | 2014 | 26 | 0.030 |
Why?
| | Tissue and Organ Harvesting | 1 | 2014 | 75 | 0.030 |
Why?
| | Tamoxifen | 1 | 2014 | 202 | 0.030 |
Why?
| | Microcirculation | 1 | 2014 | 150 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2024 | 5537 | 0.030 |
Why?
| | Attitude of Health Personnel | 1 | 2021 | 1159 | 0.030 |
Why?
| | Colorado | 1 | 2023 | 4532 | 0.020 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2014 | 141 | 0.020 |
Why?
| | Cell Line, Tumor | 2 | 2011 | 3408 | 0.020 |
Why?
| | Linear Models | 1 | 2014 | 856 | 0.020 |
Why?
| | Blotting, Western | 1 | 2014 | 1230 | 0.020 |
Why?
| | Energy Intake | 1 | 2014 | 506 | 0.020 |
Why?
| | Up-Regulation | 1 | 2014 | 854 | 0.020 |
Why?
| | Bevacizumab | 1 | 2011 | 139 | 0.020 |
Why?
| | Risk Factors | 1 | 2024 | 10426 | 0.020 |
Why?
| | Mice, Nude | 1 | 2011 | 689 | 0.020 |
Why?
| | Adult | 2 | 2023 | 38389 | 0.020 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2011 | 286 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2009 | 150 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 175 | 0.020 |
Why?
| | Down-Regulation | 1 | 2011 | 638 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2015 | 1102 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2009 | 183 | 0.020 |
Why?
| | Weight Loss | 1 | 2014 | 785 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2011 | 668 | 0.020 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2011 | 875 | 0.020 |
Why?
| | Transfection | 1 | 2009 | 942 | 0.020 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2011 | 530 | 0.020 |
Why?
| | Base Sequence | 1 | 2009 | 2182 | 0.010 |
Why?
| | Biomarkers | 1 | 2017 | 4115 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2014 | 5165 | 0.010 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2011 | 1399 | 0.010 |
Why?
| | Phosphorylation | 1 | 2009 | 1770 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2009 | 2928 | 0.010 |
Why?
| | Computational Biology | 1 | 2009 | 650 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2009 | 4182 | 0.010 |
Why?
|
|
Diaz-Miron's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|